{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:46:31Z","timestamp":1790811991046,"version":"4.1.0"},"reference-count":145,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T00:00:00Z","timestamp":1342569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Ovarian cancer represents one of the cancers with the worst prognostic in adult women. More than half of the patients who present with clinical signs such as abdominal bloating and a feeling of fullness already show advanced stages. The majority of ovarian cancers grow as cystic masses, and cancer cells easily spread into the pelvic cavity once the cysts rupture or leak. When the ovarian cancer cells disseminate into the peritoneal cavity, metastatic nests may grow in the cul-de-sac, and in more advanced stages, the peritoneal surfaces of the upper abdomen become the next largest soil for cancer progression. Ascites is also produced frequently in ovarian cancers, which facilitates distant metastasis. Clinicopathologic, epidemiologic and molecular studies on ovarian cancers have improved our understanding and therapeutic approaches, but still further efforts are required to reduce the risks in the patients who are predisposed to this lethal disease and the mortality of the patients in advanced stages. Among various molecules involved in ovarian carcinogenesis, special genes such as TP53, BRCA1 and BRCA2 have been well investigated. These genes are widely accepted as the predisposing factors that trigger malignant transformation of the epithelial cells of the ovary. In addition, adnexal inflammatory conditions such as chronic salpingitis and ovarian endometriosis have been great research interests in the context of carcinogenic background of ovarian cancers. In this review, I discuss the roles of stromal cells and inflammatory factors in the carcinogenesis and progression of ovarian cancers.<\/jats:p>","DOI":"10.3390\/cancers4030701","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T11:49:47Z","timestamp":1342698587000},"page":"701-724","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Ovarian Cancer Stroma: Pathophysiology and the Roles in Cancer Development"],"prefix":"10.3390","volume":"4","author":[{"given":"Mitsuko","family":"Furuya","sequence":"first","affiliation":[{"name":"Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2012,7,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1056\/NEJM199311183292108","article-title":"Cancer of the ovary","volume":"329","author":"Cannistra","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"426","article-title":"Advances in the management of epithelial ovarian cancer","volume":"50","author":"Berkenblit","year":"2005","journal-title":"J. Reprod. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004347-200004000-00010","article-title":"Immunohistochemical detection of the Wilms\u2019 tumor gene (WT1) in epithelial ovarian tumors","volume":"19","author":"Shimizu","year":"2000","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_4","first-page":"255","article-title":"Ovarian surface epithelium: Biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e6454","DOI":"10.1371\/journal.pone.0006454","article-title":"Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia","volume":"4","author":"Cai","year":"2009","journal-title":"PLoS One"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/sj.bjc.6690199","article-title":"The expression of CCAAT\/enhancer binding protein (C\/EBP) in the human ovary in vivo: Specific increase in C\/EBPbeta during epithelial tumour progression","volume":"79","author":"Sundfeldt","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1210\/en.2011-1766","article-title":"The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts","volume":"153","author":"Gendronneau","year":"2012","journal-title":"Endocrinology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0893-3952(22)04456-8","article-title":"Origins and molecular pathology of ovarian cancer","volume":"18","author":"Bell","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_9","first-page":"151","article-title":"Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00000478-200306000-00003","article-title":"Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: A clinicopathologic analysis of 135 cases","volume":"27","author":"Sehdev","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: A mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PAS.0b013e31802cbbe9","article-title":"The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: A morphologic and molecular genetic analysis","volume":"31","author":"Dehari","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e318229449f","article-title":"Papillary tubal hyperplasia: The putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis","volume":"35","author":"Kurman","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","volume":"8","author":"Press","year":"2008","journal-title":"BMC Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","article-title":"Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: Report of 6 cases and review of the literature","volume":"30","author":"Carcangiu","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAP.0b013e3180504abf","article-title":"From Krukenberg to today: The ever present problems posed by metastatic tumors in the ovary. Part II","volume":"14","author":"Young","year":"2007","journal-title":"Adv. Anat. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00000478-199710000-00004","article-title":"The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: A clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites","volume":"21","author":"Ronnett","year":"1997","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/modpathol.3800260","article-title":"Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma","volume":"18","author":"Logani","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.pas.0000213281.43036.bb","article-title":"Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: Analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases","volume":"30","author":"Vang","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.3800698","article-title":"Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: Comparison with CK20 and correlation with coordinate expression of CK7","volume":"19","author":"Vang","year":"2006","journal-title":"Mod. Pathol."},{"key":"ref_26","first-page":"777","article-title":"K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary","volume":"139","author":"Enomoto","year":"1991","journal-title":"Am. J. Pathol."},{"key":"ref_27","first-page":"33","article-title":"Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors","volume":"54","author":"Ichikawa","year":"1994","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0090-8258(03)00264-6","article-title":"Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma","volume":"90","author":"Gemignani","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.humpath.2004.07.019","article-title":"Molecular genetic alterations in endometrioid carcinomas of the ovary: Similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas","volume":"35","author":"Catasus","year":"2004","journal-title":"Hum. Pathol."},{"key":"ref_30","first-page":"2095","article-title":"Frequent PTEN\/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors","volume":"58","author":"Obata","year":"1998","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)65148-6","article-title":"beta-Catenin expression pattern in stage I and II ovarian carcinomas : Relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome","volume":"155","author":"Gamallo","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00019606-200106000-00008","article-title":"beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas","volume":"10","author":"Gamallo","year":"2001","journal-title":"Diagn. Mol. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.pgp.0000225844.59621.9d","article-title":"Recent advances in the pathology and classification of ovarian germ cell tumors","volume":"25","author":"Roth","year":"2006","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_36","first-page":"39","article-title":"Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: An update","volume":"24","author":"Baker","year":"2005","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","article-title":"Mutation of FOXL2 in granulosa-cell tumors of the ovary","volume":"360","author":"Shah","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.2688","article-title":"Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers","volume":"221","author":"Kim","year":"2010","journal-title":"J. Pathol."},{"key":"ref_39","first-page":"788","article-title":"Ovarian and extraovarian endometriosis-associated cancer","volume":"100","author":"Modesitt","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000052853","article-title":"Implantation versus infiltration: The Sampson versus the endometriotic disease theory","volume":"47","author":"Koninckx","year":"1999","journal-title":"Gynecol. Obstet. Invest."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0002-9378(91)90254-O","article-title":"A reappraisal of the coelomic metaplasia theory by reviewing endometriosis occurring in unusual sites and instances","volume":"165","author":"Suginami","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0002-9378(91)90255-P","article-title":"Secondary mullerian system and endometriosis","volume":"165","author":"Fujii","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0015-0282(00)01752-0","article-title":"Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium","volume":"75","author":"Bergqvist","year":"2001","journal-title":"Fertil. Steril."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(97)81470-7","article-title":"Distribution of heat shock proteins in eutopic and ectopic endometrium in endometriosis and adenomyosis","volume":"68","author":"Ota","year":"1997","journal-title":"Fertil. Steril."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/09513590310001653044","article-title":"Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: Relationships with lymphocyte subsets","volume":"18","author":"Gallinelli","year":"2004","journal-title":"Gynecol. Endocrinol."},{"key":"ref_46","first-page":"429","article-title":"Immune-endocrine interactions in endometriosis","volume":"1","author":"Cakmak","year":"2009","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/4.5.741","article-title":"Endometriotic disease: The role of peritoneal fluid","volume":"4","author":"Koninckx","year":"1998","journal-title":"Hum. Reprod. Update"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/092986711794088416","article-title":"Role of natural killer cell activity in the pathogenesis of endometriosis","volume":"18","author":"Sikora","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/0962935031000134842","article-title":"The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis","volume":"12","author":"Szyllo","year":"2003","journal-title":"Mediators Inflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004347-200104000-00004","article-title":"Malignancy in endometriosis: Frequency and comparison of ovarian and extraovarian types","volume":"20","author":"Stern","year":"2001","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0020-7292(97)00238-5","article-title":"Prevalence of ovarian endometriosis in epithelial ovarian cancer","volume":"59","author":"Jimbo","year":"1997","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1525-1438.2006.00754.x","article-title":"Risk of developing ovarian cancer among women with ovarian endometrioma: A cohort study in Shizuoka, Japan","volume":"17","author":"Kobayashi","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/humrep\/dei462","article-title":"Endometriosis and the risk of cancer with special emphasis on ovarian cancer","volume":"21","author":"Melin","year":"2006","journal-title":"Hum. Reprod."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2559.1997.d01-592.x","article-title":"Ovarian atypical endometriosis: Its close association with malignant epithelial tumours","volume":"30","author":"Fukunaga","year":"1997","journal-title":"Histopathology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7150\/jca.2.94","article-title":"Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: Clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development","volume":"2","author":"Zhao","year":"2011","journal-title":"J. Cancer"},{"key":"ref_56","first-page":"3534","article-title":"Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci","volume":"56","author":"Jiang","year":"1996","journal-title":"Cancer Res."},{"key":"ref_57","first-page":"1173","article-title":"Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts","volume":"150","author":"Jimbo","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_58","first-page":"7052","article-title":"Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: Possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary","volume":"60","author":"Sato","year":"2000","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.semcdb.2009.11.017","article-title":"Origin and function of tumor stroma fibroblasts","volume":"21","author":"Xouri","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/gut.2005.079459","article-title":"Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas","volume":"55","author":"Ishiguro","year":"2006","journal-title":"Gut"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ng1013","article-title":"Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas","volume":"32","author":"Kurose","year":"2002","journal-title":"Nat. Genet."},{"key":"ref_62","first-page":"2562","article-title":"Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis","volume":"60","author":"Moinfar","year":"2000","journal-title":"Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s13402-011-0061-5","article-title":"Cervical carcinoma-associated fibroblasts are DNA diploid and do not show evidence for somatic genetic alterations","volume":"34","author":"Corver","year":"2011","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ijc.11733","article-title":"Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p","volume":"109","author":"Tuhkanen","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/ijc.21785","article-title":"Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas","volume":"119","author":"Tuhkanen","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng.117","article-title":"No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas","volume":"40","author":"Qiu","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/carcin\/bgr230","article-title":"Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness","volume":"33","author":"Cai","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijc.25961","article-title":"The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer","volume":"130","author":"Yamamura","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_70","first-page":"1445","article-title":"Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin","volume":"148","author":"Skubitz","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/cncr.10870","article-title":"Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis","volume":"95","author":"Smith","year":"2002","journal-title":"Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/modpathol.2010.75","article-title":"Alternate mucoid and hyalinized stroma in clear cell carcinoma of the ovary: Manifestation of serial stromal remodeling","volume":"23","author":"Kato","year":"2010","journal-title":"Mod. Pathol."},{"key":"ref_73","first-page":"475","article-title":"The efficacy of amiodarone in the treatment of refractory nonsustained ventricular tachycardia","volume":"40","author":"Ballas","year":"1991","journal-title":"Md. Med. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9440(10)63306-8","article-title":"Differential gene expression in ovarian carcinoma: Identification of potential biomarkers","volume":"165","author":"Hibbs","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/scbi.2000.0364","article-title":"Towards a mechanistic understanding of tumor invasion\u2014Lessons from the alpha6beta 4 integrin","volume":"11","author":"Mercurio","year":"2001","journal-title":"Semin. Cancer Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ijc.2910540112","article-title":"Integrin expression in cutaneous malignant melanoma: Association of the alpha 3\/beta 1 heterodimer with tumor progression","volume":"54","author":"Natali","year":"1993","journal-title":"Int. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ijc.1625","article-title":"Integrin alpha3 expression as a prognostic factor in colon cancer: Association with MRP-1\/CD9 and KAI1\/CD82","volume":"97","author":"Hashida","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1083\/jcb.200204056","article-title":"An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology","volume":"158","author":"Kazarov","year":"2002","journal-title":"J. Cell Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/0008-5472.CAN-04-3123","article-title":"Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: Morphologic alteration and reduced expression of beta1 integrin subsets","volume":"65","author":"Furuya","year":"2005","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/labinvest.3700657","article-title":"CD151 dynamics in carcinoma-stroma interaction: Integrin expression, adhesion strength and proteolytic activity","volume":"87","author":"Hasegawa","year":"2007","journal-title":"Lab. Invest."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/hupa.2001.21558","article-title":"Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography","volume":"32","author":"Furuya","year":"2001","journal-title":"Hum. Pathol."},{"key":"ref_82","first-page":"1239","article-title":"Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2","volume":"33","author":"Brun","year":"2008","journal-title":"Int. J. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2008.09.025","article-title":"Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma","volume":"112","author":"Adley","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0959-8049(03)00427-1","article-title":"Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma","volume":"39","author":"Manenti","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/gyno.2000.5856","article-title":"Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms","volume":"78","author":"Furuya","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"ref_86","first-page":"5224","article-title":"Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation","volume":"63","author":"Belotti","year":"2003","journal-title":"Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000055932","article-title":"Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors","volume":"68","author":"Furuya","year":"2000","journal-title":"Pathobiology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/1078-0432.CCR-04-2304","article-title":"Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients","volume":"11","author":"Ho","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e33214","DOI":"10.1371\/journal.pone.0033214","article-title":"Inhibition of mesothelin as a novel strategy for targeting cancer cells","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: A new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J. Biol Chem"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1074\/jbc.M806776200","article-title":"A binding domain on mesothelin for CA125\/MUC16","volume":"284","author":"Kaneko","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1158\/1078-0432.CCR-10-2275","article-title":"Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers","volume":"16","author":"Hassan","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"ref_96","first-page":"114","article-title":"Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity","volume":"60","author":"Fujii","year":"2000","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ygyno.2004.08.016","article-title":"Allelic imbalances in endometrial stromal neoplasms: Frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues","volume":"95","author":"Moinfar","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10552-008-9125-x","article-title":"Hormone therapy and ovarian cancer: Incidence and survival","volume":"19","author":"Wernli","year":"2008","journal-title":"Cancer Causes Control"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jsbmb.2012.05.006","article-title":"Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells","volume":"132","author":"Badia","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1158\/1078-0432.CCR-05-1244","article-title":"The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer","volume":"11","author":"Wolf","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_102","first-page":"1108","article-title":"Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites","volume":"8","author":"Milliken","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L","article-title":"Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer","volume":"72","author":"Moradi","year":"1993","journal-title":"Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cyto.2008.01.011","article-title":"Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer","volume":"42","author":"Mustea","year":"2008","journal-title":"Cytokine"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1200\/JCO.1998.16.5.1861","article-title":"Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer","volume":"16","author":"Zeimet","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1185\/030079903125002216","article-title":"Chemokines: Key players in cancer","volume":"19","author":"Arya","year":"2003","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10555-006-9003-5","article-title":"The multifaceted roles of chemokines in malignancy","volume":"25","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1172\/JCI3145","article-title":"Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer","volume":"102","author":"Arenberg","year":"1998","journal-title":"J. Clin. Invest."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1359-6101(01)00033-8","article-title":"Chemokines in cancer","volume":"13","author":"Vicari","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401003301","article-title":"Chemokines in cancer","volume":"3","author":"Frederick","year":"2001","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1158\/0008-5472.CAN-09-4341","article-title":"Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: Implications for antiangiogenic therapy","volume":"70","author":"Agarwal","year":"2010","journal-title":"Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"24584","DOI":"10.1074\/jbc.M112275200","article-title":"Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18\/pulmonary and activation-regulated chemokine in ovarian carcinoma","volume":"277","author":"Schutyser","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The functional role of the ELR motif in CXC chemokine-mediated angiogenesis","volume":"270","author":"Strieter","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI9775","article-title":"Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity","volume":"107","author":"Romagnani","year":"2001","journal-title":"J. Clin. Invest."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bcp.2004.05.030","article-title":"Recent developments in the inhibition of angiogenesis: Examples from studies on platelet factor-4 and the VEGF\/VEGFR system","volume":"68","author":"Bikfalvi","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V91.9.3289","article-title":"Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization","volume":"91","author":"Perollet","year":"1998","journal-title":"Blood"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/blood.V94.3.984.415k31_984_993","article-title":"Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action","volume":"94","author":"Jouan","year":"1999","journal-title":"Blood"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-03-1757","article-title":"Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes","volume":"64","author":"Kawada","year":"2004","journal-title":"CancerRes."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.4049\/jimmunol.167.11.6576","article-title":"A functional IFN-gamma-inducible protein-10\/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan","volume":"167","author":"Soejima","year":"2001","journal-title":"J. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ygyno.2011.05.034","article-title":"Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis","volume":"122","author":"Furuya","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/cbt.20084","article-title":"Impaired CXCL4 Expression in Tumor-Associated Macrophages (TAMs) of Ovarian Cancers Arising in Endometriosis","volume":"13","author":"Furuya","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"ref_122","first-page":"4961","article-title":"Epithelial cancer cell migration: A role for chemokine receptors?","volume":"61","author":"Scotton","year":"2001","journal-title":"Cancer Res."},{"key":"ref_123","first-page":"5930","article-title":"Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer","volume":"62","author":"Scotton","year":"2002","journal-title":"Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/0008-5472.465.65.2","article-title":"CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers","volume":"65","author":"Kryczek","year":"2005","journal-title":"Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4049\/jimmunol.164.2.733","article-title":"Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma","volume":"164","author":"Sica","year":"2000","journal-title":"J. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.4049\/jimmunol.0903247","article-title":"CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells","volume":"184","author":"Nesbeth","year":"2010","journal-title":"J. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A","article-title":"Vascular endothelial growth factor expression in early stage ovarian carcinoma","volume":"80","author":"Paley","year":"1997","journal-title":"Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3835(97)00350-9","article-title":"Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas","volume":"121","author":"Hartenbach","year":"1997","journal-title":"Cancer Lett."},{"key":"ref_129","first-page":"3193","article-title":"Preoperative serum vascular endothelial growth factor levels: Significance in ovarian cancer","volume":"8","author":"Cooper","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.2174\/138161209788453275","article-title":"Angiogenesis: Complexity of tumor vasculature and microenvironment","volume":"15","author":"Furuya","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"15505","DOI":"10.1073\/pnas.0710686105","article-title":"Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer","volume":"105","author":"Miyahara","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/CJI.0b013e318195b59e","article-title":"Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells","volume":"32","author":"Leveque","year":"2009","journal-title":"J. Immunother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/bcr2195","article-title":"IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines","volume":"10","author":"Zhu","year":"2008","journal-title":"Breast Cancer Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway","volume":"206","author":"Wang","year":"2009","journal-title":"J. Exp Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1158\/0008-5472.CAN-08-0206","article-title":"Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17","volume":"68","author":"Nam","year":"2008","journal-title":"Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.immuni.2009.09.014","article-title":"T helper 17 cells promote cytotoxic T cell activation in tumor immunity","volume":"31","author":"Muranski","year":"2009","journal-title":"Immunity"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm1699","article-title":"Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy","volume":"14","author":"Buckanovich","year":"2008","journal-title":"Nat. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/gyno.1996.0060","article-title":"Primary peritoneal serous papillary carcinoma: A study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma","volume":"60","author":"Sivan","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/01.pas.0000168174.25664.04","article-title":"Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps","volume":"29","author":"Euscher","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.pap.0000201832.15591.1d","article-title":"Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: A review and update","volume":"13","author":"Ordonez","year":"2006","journal-title":"Adv. Anat. Pathol."},{"key":"ref_142","first-page":"490","article-title":"Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum","volume":"55","author":"Muto","year":"1995","journal-title":"Cancer Res."},{"key":"ref_143","first-page":"596","article-title":"BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum","volume":"92","author":"Bandera","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00428-007-0479-3","article-title":"Primary retroperitoneal mucinous cystadenoma with sarcoma-like mural nodule : A case report and review of the literature","volume":"451","author":"Bakker","year":"2007","journal-title":"Virchows Arch."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/gyno.1996.0115","article-title":"Primary retroperitoneal mucinous cystadenocarcinoma of low malignant potential: a case report and literature review","volume":"61","author":"Pearl","year":"1996","journal-title":"Gynecol. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/4\/3\/701\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:51:20Z","timestamp":1760219480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/4\/3\/701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,18]]},"references-count":145,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,9]]}},"alternative-id":["cancers4030701"],"URL":"https:\/\/doi.org\/10.3390\/cancers4030701","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,18]]}}}